Multimodality therapy for stage III non-small-cell lung cancer

Journal of Clinical Oncology

Volumn 23, Issue 14, 2005, Pages 3257-3269

  Farray, Daniel ^a   Mirkovic, Nena ^a   Albain, Kathy S ^a  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOCETAXEL; ETOPOSIDE; GEMCITABINE; IRINOTECAN; LOMUSTINE; MITOMYCIN; NAVELBINE; PACLITAXEL; VINBLASTINE; VINDESINE;

ADJUVANT THERAPY; ADVANCED CANCER; AREA UNDER THE CURVE; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; DRUG BIOAVAILABILITY; DRUG DOSE REDUCTION; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; DYSPHAGIA; ESOPHAGITIS; HUMAN; LUNG NON SMALL CELL CANCER; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; REVIEW; TUMOR VOLUME; CONTROLLED CLINICAL TRIAL; LUNG TUMOR; MULTIMODALITY CANCER THERAPY; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL;

CARCINOMA, NON-SMALL-CELL LUNG; COMBINED MODALITY THERAPY; HUMANS; LUNG NEOPLASMS; NEOPLASM STAGING; RANDOMIZED CONTROLLED TRIALS;

EID: 19844364466     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.03.008     Document Type: Review

References (72)

1. Andre F, Grunenwald D, Pignon JP, et al: Survival of patients with resected N2 non-small-cell lung cancer: Evidence for a subclassification and implications. J Clin Oncol 18:2981-2989, 2001
2. Martini N, Flehinger BJ, Zaman MB, et al: Results of resection in non-oat cell carcinoma of the lung with mediastinal lymph node metastases. Ann Surg 198:386-397, 1983
3. Pearson FG, DeLarue NC, Ilves R, et al: Significance of positive superior mediastinal nodes identified at mediastinoscopy in patients with resectable cancer of the lung. J Thorac Cardiovasc Surg 83:1-11, 1982
4. Dillman RO, Herndon J, Seagren SL, et al: Improved survival in stage III non-small-cell lung cancer: Seven-year follow-up of Cancer and Leukemia Group B (CALGB) 8433 trial. J Natl Cancer Inst 88:1210-1215, 1996
5. Sause W, Kolesar P, Taylor S, et al: Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer: Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, Southwest Oncology Group. Chest 117:358-364, 2000
6. Le Chevalier T, Arraigada R, Quoix E, et al: Radiotherapy alone versus combined chemotherapy and radiotherapy in unresectable non-small cell lung carcinoma. Lung Cancer 10:S239-S244, 1994(suppl 1)
7. Furuse K, Fukuoka M, Kawahara M, et al: Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer. J Clin Oncol 17:2692-2699, 1999
8. Pierre F, Perol M, Gilles R, et al: A randomized phase III trial of sequential chemoradiotherapy versus concurrent chemo-radiotherapy in locally advanced non small cell lung cancer (GLOT-GFPC NPC 95-01 study). Proc Am Soc Clin Oncol 20: 312a, 2001 (abstr 1246)
9. Curran WJ, Scott CB, Langer CJ, et al: Long-term benefit is observed in a phase III comparison of sequential versus concurrent chemo-radiation for patients with unresected stage III nsclc: RTOG 9410. Proc Am Soc Clin Oncol 22:621, 2003 (abstr 2499)
10. Zatloukal P, Petruzelka L, Zemanova M, et al: Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: A randomized study. Lung Cancer 46:87-98, 2004
11. Schaake-Koning C, van der Bogaert W, Dalesio O, et al: Effects of concomitant cisplatin and radiotherapy on inoperable non-small cell lung cancer. N Engl J Med 326:524-530, 1992
12. Albain KS, Crowley JJ, Turrisi AT, et al: Concurrent cisplatin, etoposide, and chest radiotherapy in pathologic stage IIIB non-small cell lung cancer: A Southwest Oncology Group phase II study, SWOG 9019. J Clin Oncol 20:3454-3460, 2002
13. Gandara DR, Chansky K, Albain KS, et al: Consolidation docetaxel after concurrent chemoradiotherapy in stage IIIB non-small cell lung cancer: Phase II Southwest Oncology Group study S9504. J Clin Oncol 21:2004-2010, 2003
14. Sause WT, Scott CB, Byhardt RW, et al: Phase I/II trial of combination chemotherapy and irradiation in non-small cell lung cancer, Radiation Therapy Oncology Group 88-04. Am J Clin Oncol 15:163-167, 1992
15. Vokes EE, Herndon JE, Crawford J, et al: Randomized phase II study of cisplatin with gemcitabine or paclitaxel or vinorelbine as induction chemotherapy followed by concomitant chemoradiotherapy for stage IIIB non-small-cell lung cancer: Cancer and Leukemia Group B study 9431. J Clin Oncol 20:4191-4198, 2002
16. Choy H, Curran WJ, Scott CB, et al: Preliminary report of locally advanced multimodality protocol (LAMP): ACR 427: A randomized phase II study of three chemo-radiation regimens with paclitaxel, carboplatin, and thoracic radiation for patients with locally advanced non small cell lung cancer. Proc Am Soc Clin Oncol 21:291, 2002 (abstr 1160)
17. Huber RM, Scmidt M, Flentje M et al: Induction chemotherapy and following simultaneous radio/chemotherapy versus induction chemotherapy and radiotherapy alone in inoperable NSCLC (stage IIIA/IIIB). Proc Am Soc Clin Oncol 22:622, 2003 (abstr 2501)
18. Vokes EE, Hemdon JE, Kelley MJ, et al: Induction chemotherapy followed by concomitant chemoradiotherapy versus chemoradiotherapy alone for regionally advanced unresectable non-small cell lung cancer: initial analysis of a randomized phase III trial. J Clin Oncol 22:14S, 2004 (suppl; abstr 7005)
19. Socinski MA, Morris DE, Halle JS, et al: Induction and concurrent chemotherapy with high-dose thoracic conformal radiation therapy in unresectable stage IIIA and IIIB non-small-cell lung cancer: A dose-escalation phase I trial. J Clin Oncol 22:4341-4349, 2004
20. Warram J: Preoperative irradiation of cancer of the lung: Final report of a therapeutic trial. A collaborative study. Cancer 36:914-925, 1975
21. Roth JA, Fossella F, Komaki R, et al: A randomized trial comparing preoperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small cell lung cancer. J Natl Cancer Inst 86:673-680, 1994
22. Rosell R, Gomez-Codina J, Camps C, et al: A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer. N Engl J Med 330:153-158, 1994
23. Pass HI, Pogrebniak HW, Steinberg SM, et al: Randomized trial of neoadjuvant therapy for lung cancer: interim analysis. Ann Thorac Surg 53:992-998, 1992
24. Depierre A, Milleron B, Moro-Sibilot D, et al: Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N0), II and IIIa non-small-cell lung cancer. J Clin Oncol 20:247-253, 2002
25. Pisters KM, Ginsberg RJ, Giroux DJ, et al: Induction chemotherapy before surgery for early-stage lung cancer: A novel approach. J Thorac Cardiovasc Surg 119:429-439, 2000
26. Pisters KM, Ginsberg RJ, Giroux DJ, et al: Bimodality Lung Oncology Team (BLOT) trial of induction paclitaxel/carboplatin in early stage non-small cell lung cancer (NSCLC): Long term followup of a phase II trial. Proc Am Soc Clin Oncol 22:633, 2003 (abstr 2544)
27. Betticher DC, Scmitz SH: Totsch M, et al: Mediastinal lymph node clearance after docetaxel-cisplatin neoadjuvant chemotherapy is prognostic of survival in patients with stage IIIA pN2 non-small-cell lung cancer: A multicenter phase II trial. J Clin Oncol 21:1752-1759, 2003
28. De Marinis F, Nelli F, Migliorino M, et al: Gemcitabine, paclitaxel, and cisplatin as induction chemotherapy for patients with biopsy-proven stage IIIA (N2) nonsmall cell lung carcinoma: A phase II multicenter study. Cancer 98:1707-1715, 2003
29. Splinter TA, van Schil PE, Kramer GW, et al: Randomized trial of surgery versus radiotherapy in patients with stage IIIA (N2) non-small cell lung cancer after a response to induction chemotherapy. EORTC 08941. Clin Lung Cancer 2:69-72, 2000
30. Van Zandwijk N, Smit EF, Kramer GW, et al: Gemcitabine and cisplatin as induction regimen for patients with biopsy-proven stage IIIA N2 non-small-cell lung cancer: A phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group (EORTC 08955). J Clin Oncol 18:2658-2664, 2000
31. O'Brien ME, Splinter T, Smit EF, et al: Carboplatin and paclitaxel (Taxol) as an induction regimen for patients with biopsy-proven stage IIIA N2 non-small cell lung cancer. An EORTC phase II study (EORTC 08958). Eur J Cancer 39:1416-1422, 2003
32. Manegold C, Biesma B, Smit H, et al: Docetaxel and cisplatin as induction chemotherapy in stage III N2 non-small cell lung cancer (NSCLC): An EORTC phase II trial (08984). J Clin Oncol 22:14S, 2004 (suppl; abstr 7166)
33. Cappuzzo F, Selvaggi G, Gregorc V, et al: Gemcitabine and cisplatin as induction chemotherapy for patients with unresectable stage IIIA-bulky N2 and stage IIIB nonsmall cell lung carcinoma: An Italian Lung Cancer Project Observational Study. Cancer 98:128-134, 2003
34. Arrigada R, Bergman B, Dunant A, et al: Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Engl J Med 350:351-360, 2004
35. Kato H, Ichinose Y, Ohta M, et al: A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung. N Engl J Med 350:1713-1721, 2004
36. Winton TL, Livingston R: Johnson D, et al: A prospective randomised trial of adjuvant vinorelbine (VIN) and cisplatin (CIS) in completely resected stage 1B and II non small cell lung cancer (NSCLC) Intergroup JBR.10. J Clin Oncol 22:14S, 2004 (suppl; abstr 7018)
37. Strauss GM, Herndon J, Maddaus MA, et al: Randomized clinical trial of adjuvant chemotherapy with paclitaxel and carboplatin following resection in stage IB non-small cell lung cancer (NSCLC): Report of Cancer and Leukemia Group B (CALGB) Protocol 9633. J Clin Oncol 22:145, 2004 (suppl; abstr 7019)
38. Eberhardt WE, Albain KS, Pass H, et al: Induction treatment before surgery for non-small cell lung cancer. Lung Cancer 42:S9-S14, 2003
39. Albain KS, Scott CB, Rusch VR, et al: Phase III comparison of concurrent chemotherapy plus radiotherapy (CT/radiotherapy) and CT/ radiotherapy followed by surgical resection for stage IIIA(pN2) non-small cell lung cancer (NSCLC): Initial results from Intergroup trial 0139 (RTOG 93-09). Proc Am Soc Clin Oncol 22:621, 2003 (abstr 2497)
40. Albain KS, Rusch VW, Crowley JJ, et al: Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: Mature results of southwest oncology group phase II study 8805. J Clin Oncol 13:1880-1892, 1995
41. Ruebe C, Riesenbeck D, Semik M, et al: Neoadjuvant chemotherapy followed by preoperative radiochemotherapy (hfRTCT) plus surgery or surgery plus postoperative radiotherapy in stage III non-small cell lung cancer: Results of a randomized phase III trial of the German Lung Cancer Cooperative Group. Int J Radiat Oncol Biol Phys 60:S130, 2004 (1 suppl)
42. Katayama H, Ueoka H, Kiura K, et al: Preoperative concurrent chemoradiotherapy with cisplatin and docetaxel in patients with locally advanced non-small-cell lung cancer. Br J Cancer 90:979-984, 2004
43. Eberhardt W, Le Pechoux C, Gauler T: Multicenter German/French phase-II trial of induction chemotherapy (CTx) followed by hyperfractionated accelerated thoracic radiotherapy concurrent with CTx +/- surgery in locally advanced inoperable non-small-cell lung cancer stage III patients-Mature results of a novel induction CTx regimen. Lung Cancer 46:S40-S41, 2004
44. Vora SA, Daly BD, Blaszkowsky L, et al: High dose radiation therapy and chemotherapy as induction treatment for stage III nonsmall cell lung carcinoma. Cancer 89:1946-1952, 2000
45. Cox JD, Pajak TF, Asbell S, et al: Interruptions of high-dose radiation therapy decrease long-term survival of favorable patients with unresectable non-small cell carcinoma of the lung: Analysis of 1244 cases from 3 Radiation Therapy Oncology Group (RTOG) trials. Int J Radiat Oncol Biol Phys 27:493-498, 1993
46. Jeremic B, Shibamoto Y, Milicic B, et al: Impact of treatment interruptions due to toxicity on outcome of patients with early stage (I/II) non-small-cell lung cancer (NSCLC) treated with hyperfractionated radiation therapy alone. Lung Cancer 40:317-323, 2003
47. Southwest Oncology Group Protocol Information: S022. Phase II trial of concurrent cisplatin/docetaxel and radiotherapy followed by consolidation docetaxel in stage IIIB non-small cell lung cancer. http://www.swog.org/ Visitors/ ViewProtocolDetails.asp?ProtocolID=1832
48. Shaw RR, Paulson DL, Kee JL Jr: Treatment of the superior sulcus tumor by irradiation followed by resection. Ann Surg 7:29-40, 1961
49. Rusch VW, Parekh KR, Leon L, et al: Factors determining outcome after surgical resection of T3 and T4 lung cancers of the superior sulcus. J Thorac Cardiovasc Surg 119:1147-1153, 2000
50. Rusch VW, Giroux DJ, Kraut MJ, et al: Induction chemoradiation and surgical resection for non-small cell lung carcinomas of the superior sulcus: Initial results of Southwest Oncology Group trial 9416 (intergroup trial 0160). J Thorac Cardiovasc Surg 121:472-483, 2001
51. Rusch VW, Giroux DJ, Kraut MJ, et al: Induction chemoradiation and surgical resection for non-small cell lung carcinomas of the superior sulcus: Mature results of Southwest Oncology Group trial 9416 (intergroup trial 0160). Proc Am Soc Clin Oncol 22:634, 2003 (abstr 2548)
52. Figlin RA, Piantadosi S, Feld R: Intracranial recurrence of carcinoma after complete surgical resection of stage I, II and III non-small-cell lung cancer. New Engl J Med 318:1300-1305, 1988
53. Cox JD, Scott CB, Byhardt RW, et al: Addition of chemotherapy to radiotherapy alters failure patterns by cell type within non-small cell carcinoma of the lung (NSCLC): Analysis of radiation Therapy Oncology Group (RTOG) trials. Int J Radiat Oncol Biol Phys 43:505-509, 1999
54. Komaki R, Scott CB, Byhardt RW, et al: Failure patterns by prognostic group determined by recursive partitioning analysis (RPA) of 1547 patients on four Radiation Therapy Oncology Group studies in inoperable non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 42:263-267, 1988
55. Robnett TJ, Machtay M, Stevenson JP, et al: Factors affecting the risk of brain metastases after definitive chemoradiation for locally advanced non-small-cell lung cancer. J Clin Oncol 19:1344-1349, 2001
56. Keith B, Vincent M, Stit L, et al: Subsets more likely to benefit from surgery or prophylactic cranial irradiation after chemoradiation for localized non-small-cell lung cancer. Am J Clin Oncol 25:583-587, 2002
57. Weiden PL, Piantadosi S: Preoperative chemotherapy (cisplatin and fluorouracil) and radiation therapy in stage III non-small cell lung cancer: A phase II study of the Lung Cancer Study Group. J Natl Cancer Inst 83:266-273, 1991
58. Andre F, Grunenwald D, Pujol LJ, et al: Patterns of relapse of N2 nonsmall-cell lung carcinoma patients treated with preoperative chemotherapy. Should prophylactic cranial irradiation be reconsidered? Cancer 91:2394-2400, 2001
59. Cox JD, Stanley K, Petrovich Z, et al: Cranial irradiation in cancer of the lung in all cell types. JAMA 245:469-472, 1981
60. Kumar P, Herndon J, Langer M, et al: Patterns of disease failure after tri-modality therapy of non-small cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B protocol 8935. Cancer 77:2393-2399, 1996
61. Vora SA, Daly BDT, Blaszkowsky L, et al: High dose radiation therapy and chemotherapy as induction treatment for stage III nonsmall cell lung carcinoma. Cancer 89:1946-1952, 2000
62. Reddy S, Lee MS, Bonomi P, et al: Combined modality therapy for stage III non-small cell lung carcinoma: results of treatment and patterns of failure. Int J Radiat Oncol Biol Phys 24:17-23, 1992
63. Eberhardt W, Wilke H, Stamatis G, et al: Preoperative chemotherapy followed by concurrent chemoradiation therapy based on hyperfractionated accelerated radiotherapy and definitive surgery in locally advanced non-small cell lung cancer: Mature results of a phase II trial. J Clin Oncol 16:622-634, 1998
64. Umsawadi T, Valdivieso M, Chen TT, et al: Role of elective brain irradiation during combined chemoradiotherapy for limited disease non-small-cell lung cancer. J Neurooncol 2:253-259, 1984
65. Stuschke M, Eberhardt W, Pottgen C, et al: Prophylactic cranial irradiation in locally advanced non-small cell lung cancer after multimodality treatment: Long-term follow-up and investigations of late neuropsychologic effects. J Clin Oncol 17:2700-2709, 1999
66. Rusch VW, Griffin BR, Livingston RB: The role of prophylactic cranial irradiation in regionally advanced non-small cell lung cancer. A Southwest Oncology Group Study. J Thorac Cardiovasc Surg 98:535-539, 1989
67. Russell AH, Pajak TE, Selim HM, et al: Prophylactic cranial irradiation for lung cancer patients at high risk for development of cerebral metastases: Results of a prospective randomized trial conducted by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 21:637-643, 1991
68. Strauss GM, Herndon JE, Sherman DD, et al: Neoadjuvant chemotherapy and radiotherapy followed by surgery in stage IIIA non-small cell carcinoma of the lung: Report of a Cancer and Leukemia Group B phase II study. J Clin Oncol 10:1237-1244, 1992
69. Arriagada R, Le Chevalier T, Borie F: Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. J Natl Cancer Inst 87:183-190, 1995
70. Gregor A, Cull A, Stephens RJ, et al: Prophylactic cranial irradiation is indicated following complete response to induction therapy in small cell lung cancer: Results of multicentre randomized trial. UKCR and the EORTC. Eur J Cancer 33:1752-1758, 1997
71. Komaki R: Neurological sequelae in long-term survivors of small cell lung cancer. Int J Radiat Oncol Biol Phys 34:1181-1183, 1996
72. Johnson BE, Becker B, Goff WB, et al: Neurologic, neuropsychologic and cranial computed tomography scan abnormalities in 2-10 year survivors of small-cell lung cancer. J Clin Oncol 3:1659-1667, 1985